IOVANCE BIOTHERAPEUTICS, INC. Annual Cost of Revenue in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate for 2023.
  • Iovance Biotherapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $39.8M, a 818% increase year-over-year.
Cost of Revenue, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.8M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.